Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 18;85(18):3486-3504.e7.
doi: 10.1016/j.molcel.2025.08.021.

mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport

Sejeong Shin  1 , Min-Joon Han  2 , Ishika Patel  3 , Alia M Welsh  4 , Maria Sverdlov  5 , Wonhwa Cho  6 , Stephanie M Cologna  6 , Philippe P Roux  7 , Sang-Oh Yoon  8
Affiliations

mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport

Sejeong Shin et al. Mol Cell. .

Abstract

The mechanistic target of rapamycin (mTOR) is a key regulator of lipid homeostasis by controlling processes including lipid uptake and biosynthesis. mTOR dysregulation and consequent altered lipid metabolism are common in various diseases, including cancers, making mTOR a promising therapeutic target. Therefore, it is crucial to understand how mTOR activation and inhibition reprogram lipid homeostasis. In human cancer cell lines, mTOR inhibition induces alternative lipid uptake through translation eukaryotic initiation factor 3D (eIF3D)-mediated low-density lipoprotein receptor (LDLR)-related protein 6 (LRP6) increase and activates liver X receptor β (LXRβ), promoting cholesterol release from lysosomes and its transport to the plasma membrane via Niemann-Pick disease type C (NPC) intracellular cholesterol transporter 1 (NPC1). This signaling supports tumor cell survival and stress resistance. In mouse xenograft models, combining mTOR inhibition with LRP6 knockdown or NPC1 targeting significantly suppresses tumor growth. Our findings highlight mTOR feedback signaling in reprogramming lipid homeostasis and its therapeutic potential to treat diseases characterized by dysregulated mTOR.

Keywords: AKT; IGF1R; LRP6; NPC1; cholesterol; mTOR.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Ricoult SJ, and Manning BD (2013). The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep 14, 242–251. 10.1038/embor.2013.5. - DOI - PMC - PubMed
    1. Meza U, Delgado-Ramirez M, Romero-Mendez C, Sanchez-Armass S, and Rodriguez-Menchaca AA (2020). Functional marriage in plasma membrane: Critical cholesterol leveloptimal protein activity. Br J Pharmacol 177, 2456–2465. 10.1111/bph.15027. - DOI - PMC - PubMed
    1. Rohrig F, and Schulze A (2016). The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer 16, 732–749. 10.1038/nrc.2016.89. - DOI - PubMed
    1. Pellerin L, Carrie L, Dufau C, Nieto L, Segui B, Levade T, Riond J, and Andrieu-Abadie N (2020). Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers (Basel) 12. 10.3390/cancers12113147. - DOI - PMC - PubMed
    1. Lee MS, and Bensinger SJ (2022). Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins. Cell Mol Immunol 19, 327–336. 10.1038/s41423-021-00827-0. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources